Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
| Buy | Overweight | Hold | Underweight | Sell |
|---|---|---|---|---|
| 7 | 4 | 0 | 0 | 0 |
Analyst Firms Making Recommendations1
- Morgan Stanley
- HC Wainwright & Co.
- Cantor Fitzgerald
- Stifel
- Wells Fargo
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Cabaletta Bio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/29/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 57.04% | Morgan Stanley | Michael Ulz | $28 → $25 | Maintains | Overweight | Get Alert |
| 11/29/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 57.04% | HC Wainwright & Co. | Douglas Tsao | → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 214.07% | Cantor Fitzgerald | Joshua Schimmer | $40 → $50 | Maintains | Overweight | Get Alert |
| 11/10/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 57.04% | HC Wainwright & Co. | Douglas Tsao | $17 → $25 | Maintains | Buy | Get Alert |
| 11/08/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 75.88% | Morgan Stanley | Michael Ulz | $16 → $28 | Maintains | Overweight | Get Alert |
| 10/24/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 151.26% | Cantor Fitzgerald | Joshua Schimmer | → $40 | Initiates | → Overweight | Get Alert |
| 10/19/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 94.72% | Stifel | Ben Burnett | → $31 | Initiates | → Buy | Get Alert |
| 10/04/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 6.78% | HC Wainwright & Co. | Douglas Tsao | → $17 | Reiterates | Buy → Buy | Get Alert |
| 09/18/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 144.97% | Wells Fargo | Derek Archila | $14 → $39 | Maintains | Overweight | Get Alert |
| 09/05/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 38.19% | Citigroup | Samantha Semenkow | → $22 | Initiates | → Buy | Get Alert |
| 08/14/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 113.57% | Guggenheim | Yatin Suneja | → $34 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 6.78% | HC Wainwright & Co. | Douglas Tsao | $15 → $17 | Maintains | Buy | Get Alert |
| 07/18/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | 113.57% | Guggenheim | Yatin Suneja | → $34 | Initiates | → Buy | Get Alert |
| 05/17/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | -5.78% | HC Wainwright & Co. | Douglas Tsao | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | -5.78% | HC Wainwright & Co. | Douglas Tsao | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | -5.78% | HC Wainwright & Co. | Douglas Tsao | → $15 | Reiterates | → Buy | Get Alert |
| 04/10/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | -5.78% | HC Wainwright & Co. | Douglas Tsao | → $15 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | -5.78% | HC Wainwright & Co. | Douglas Tsao | → $15 | Reiterates | → Buy | Get Alert |
| 03/22/2023 | CABA | Buy Now | Cabaletta Bio | $15.92 | -24.62% | Chardan Capital | Geulah Livshits | → $12 | Reiterates | → Buy | Get Alert |
What is the target price for Cabaletta Bio (CABA)?
The latest price target for Cabaletta Bio (NASDAQ: CABA) was reported by Morgan Stanley on November 29, 2023. The analyst firm set a price target for $25.00 expecting CABA to rise to within 12 months (a possible 57.04% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cabaletta Bio (CABA)?
The latest analyst rating for Cabaletta Bio (NASDAQ: CABA) was provided by Morgan Stanley, and Cabaletta Bio maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Cabaletta Bio (CABA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cabaletta Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cabaletta Bio was filed on November 29, 2023 so you should expect the next rating to be made available sometime around November 29, 2024.
Is the Analyst Rating Cabaletta Bio (CABA) correct?
While ratings are subjective and will change, the latest Cabaletta Bio (CABA) rating was a maintained with a price target of $28.00 to $25.00. The current price Cabaletta Bio (CABA) is trading at is $15.92, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.